Clinical Trial: Oral vs. Subcutaneous Semaglutide in Type 2 Diabetes Mellitus
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Diabetes Mellitus Type 2
Study Type: OBSERVATIONAL
Official Title: Sex Related Outcomes in Oral vs. Subcutaneous Semaglutide in Type 2 Diabetes Mellitus: A 12-month Real-world Study
Brief Summary:
This real-world, comparative cohort study aims to evaluate the 12-month effectiveness of oral versus subcutaneous semaglutide in patients with type 2 diabetes mellitus (T2D), with a specific focus on sex-based differences in metabolic response.A total of 212 patients were enrolled and evenly assigned to either oral or subcutaneous semaglutide.The primary outcome was the change in HbA1c, while secondary outcomes included variations in weight, lipid profile, liver function, and hepatic steatosis index.Subcutaneous…
Read more